Occupation or Discipline – Page 13

Roche and Dyno Therapeutics Launch $1B+ Collaboration to Develop Next-Generation AAV Gene Therapy Vectors for Neurological Diseases

1 year ago talkbio0Tagged AAVS1 gene, Cloning Vectors, Collaboration, Dyno, gene delivery process, gene therapy, LEAP, Neurological diseases, Roche (company), Technology

Roche, Dyno Therapeutics, AAV gene therapy vectors, Neurological diseases, AI-driven gene delivery, LEAP technology, Gene therapy collaboration

Roche Revisits Dyno for AAV Technology with $50M Upfront Payment

1 year ago talkbio0Tagged AAV, AAVS1 gene, Dyno, gene therapy, Neurological diseases, Roche (company), strategic partnership, Technology

Roche, Dyno Therapeutics, AAV technology, gene therapy, neurological diseases, strategic partnership

Nucleus RadioPharma Unveils Ambitious Expansion Plan to Triple Production Capacity and Create 100 New Positions

1 year ago talkbio0Tagged CDMO, expansion, Manufacturing, Nucleus RadioPharma, Radiopharmaceuticals, Surgical construction, Therapeutic radiology procedure

Nucleus RadioPharma, Radiopharma CDMO, Manufacturing Expansion, Job Creation, Radiopharmaceuticals, Radiotherapeutics

KdT Ventures Secures $100M Fourth Fund to Fuel Early-Stage Biotech Startups

1 year ago talkbio0Tagged Early-stage, frontier, Investments, KdT, Science, startups, Ventures

KdT Ventures, $100M fund, early-stage startups, biotech, frontier science, life sciences investment

Predictive Analytics and AI: Reducing Emergency Room Visits through Enhanced Triage and Resource Allocation

1 year ago talkbio0Tagged Accident and Emergency department, Artificial Intelligence, Health care facility, Machine Learning, Optimization, Predictive analytics, Resource Allocation, Triage

Predictive analytics, Artificial intelligence (AI), Emergency department (ED) visits, Triage, Resource allocation, Machine learning (ML), Healthcare optimization

Sanofi Workers Strike Over Consumer Health Unit Sale Amid Job Loss and Strategic Asset Concerns

1 year ago talkbio0Tagged Clayton, consumer health unit, DOLIPRANE, France, losses, Opella, Sales - occupational activity, sanofi, strategic assets

Sanofi, strike, consumer health unit, sale, job losses, strategic assets, France, Doliprane, Opella, Clayton Dubilier & Rice

AI-Driven Recognition of Disease Signatures in Cellular Pathway Visualizations

1 year ago talkbio0Tagged Artificial Intelligence, Cellular Pathway, disease signatures, Machine Learning, Neural Network Simulation, Transcriptomic Analysis, Visualizations

Artificial Intelligence (AI), Neural Networks, Disease Signatures, Cellular Pathway Visualizations, Transcriptomic Analysis, Machine Learning

MeiraGTx Announces Positive Phase 2 Data for AAV-GAD Gene Therapy in Parkinson’s Disease, Paving Way for Phase 3 Trial

1 year ago talkbio0Tagged AAV-GAD, gene therapy, Genetic Medicine, MeiraGTx, Neurodegenerative Disorders, Parkinson Disease, Phase 2 trial, Phase 3 trial

MeiraGTx, AAV-GAD, Gene Therapy, Parkinson’s Disease, Phase 2 Trial, Phase 3 Trial, Neurodegenerative Disorders, Genetic Medicine

Eli Lilly Commits £279 Million to UK Life Sciences Sector in Groundbreaking Partnership

1 year ago talkbio0Tagged Biological Science Disciplines, Eli, Eli Lilly, Gateway Labs, Government, Investments, Obesity, Partnership, UK

Eli Lilly, UK life sciences, £279 million investment, Lilly Gateway Labs, obesity treatment, UK government partnership